Crossmark

Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody

Crossref DOI link: https://doi.org/10.1186/s40792-021-01297-2

Published Online: 2021-09-17

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tomioka, Yasuaki

Otani, Shinji http://orcid.org/0000-0002-5462-2919
Tanaka, Shin

Shien, Kazuhiko

Suzawa, Ken

Miyoshi, Kentaroh

Yamamoto, Hiromasa

Okazaki, Mikio

Sugimoto, Seiichiro

Yamane, Masaomi

Toyooka, Shinichi
License Information

Text and Data Mining valid from 2021-09-17

Version of Record valid from 2021-09-17
More Information

Article History

Received: 28 July 2021

Accepted: 10 September 2021

First Online: 17 September 2021

Declarations

:

: Not applicable.

: Informed consent for publication was obtained from the patient.

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below